Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD : A Historical Real-World Non-Inferiority Study
| dc.contributor.author | Voorham, Jaco | |
| dc.contributor.author | Baldi, Simonetta | |
| dc.contributor.author | Santoro, Luigi | |
| dc.contributor.author | Kerkhof, Marjan | |
| dc.contributor.author | Contoli, Marco | |
| dc.contributor.author | Kerstjens, Huib AM | |
| dc.contributor.author | Lopez-Campos, José Luis | |
| dc.contributor.author | Roche, Nicolas | |
| dc.contributor.author | Singh, Dave | |
| dc.contributor.author | Vogelmeier, Claus F | |
| dc.contributor.author | Price, David B | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-10-29T10:25:01Z | |
| dc.date.available | 2020-10-29T10:25:01Z | |
| dc.date.issued | 2020-10-29 | |
| dc.description | Acknowledgments: Dave Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). Writing and editorial support was provided by Dr Julia Granerod, supported by the Observational and Pragmatic Research Institute Pte. Ltd (OPRI). Data Sharing Statement The dataset supporting the conclusions of this article was derived from the Optimum Patient Care Research Database (www.opcrd.co.uk). The OPCRD has ethical approval from the National Health Service (NHS) Research Authority to hold and process anonymised research data (Research Ethics Committee reference: 15/EM/0150). This study was approved by the Anonymised Data Ethics Protocols and Transparency (ADEPT) committee – the independent scientific advisory committee for the OPCRD. The authors do not have permission to give public access to the study dataset; researchers may request access to OPCRD data for their own purposes. Access to OCPRD can be made via the OCPRD website (https://opcrd.co.uk/our-database/data-requests/) or via the enquiries email info@opcrd.co.uk. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 821067 | |
| dc.identifier | 177347439 | |
| dc.identifier | 5917d72f-408b-4bbf-bcf3-0ca8b2e56ac3 | |
| dc.identifier | 85094631173 | |
| dc.identifier | 33149571 | |
| dc.identifier.citation | Voorham, J, Baldi, S, Santoro, L, Kerkhof, M, Contoli, M, Kerstjens, H AM, Lopez-Campos, J L, Roche, N, Singh, D, Vogelmeier, C F & Price, D B 2020, 'Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD : A Historical Real-World Non-Inferiority Study', International journal of chronic obstructive pulmonary disease , vol. 2020, no. 15, pp. 2739—2750. https://doi.org/10.2147/COPD.S269287 | en |
| dc.identifier.doi | 10.2147/COPD.S269287 | |
| dc.identifier.iss | 15 | en |
| dc.identifier.issn | 1176-9106 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15293 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85094631173&partnerID=8YFLogxK | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International journal of chronic obstructive pulmonary disease | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | real-world | en |
| dc.subject | electronic health records | en |
| dc.subject | observational | en |
| dc.subject | comparative effectiveness | en |
| dc.subject | heterogeneity | en |
| dc.subject | chronic obstructive pulmonary disease | en |
| dc.subject | Heterogeneity | en |
| dc.subject | Comparative effectiveness | en |
| dc.subject | Observational | en |
| dc.subject | Real-world | en |
| dc.subject | Chronic obstructive pulmonary disease | en |
| dc.subject | Electronic health records | en |
| dc.subject | R Medicine | en |
| dc.subject | Public Health, Environmental and Occupational Health | en |
| dc.subject | Health Policy | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | R | en |
| dc.title | Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD : A Historical Real-World Non-Inferiority Study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Voorham_et_al_IJCOPD_ExtrafineBeclometasoneDipropionate_VoR.pdf
- Size:
- 801.82 KB
- Format:
- Adobe Portable Document Format
